Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Guidelines for the Prevention of Stroke in Women
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients
2014
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Risk of Stroke in Patients with Rheumatism: A Nationwide Longitudinal Population-based Study
2014
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis
2013
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
2014
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
2012
Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes
2012
The concept of psoriasis as a systemic inflammation: implications for disease management
2012
Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
2013
Antithrombotic Therapy for VTE Disease
2016 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink
2015
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
2011
Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
2011
Psoriasis
2021 Standout
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
2012
Psoriasis: Which therapy for which patient
2018
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
2015
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study
2012
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
2014
Artificial Intelligence in Precision Cardiovascular Medicine
2017 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Psoriasis
2015 Standout
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
2012
Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
2013
Atrial fibrillation
2011
Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
2013
Perioperative care for patients with rheumatic diseases
2011
Prevention and management of stroke in women
2015
Clopidogrel–Drug Interactions
2011
Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study
2013
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation
2015
Psoriasis and risk of cardiovascular disease: A meta-analysis of cohort studies
2013
Recommendations for detection of individual risk for comorbidities in patients with psoriasis
2013
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
2013
Antithrombotic Therapy for Atrial Fibrillation
2012
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
2013
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiplatelet Therapy and Proton Pump Inhibition
2012
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
2020
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and Stroke
2014
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
2020 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation
2012
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study
2016
Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation
2016
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review
2013
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
2012
Prosthetic Joint Infection
2014 Standout
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
2013
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
2012
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
2016
An Updated Definition of Stroke for the 21st Century
2013 Standout
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
2018
Association of psoriasis with stroke and myocardial infarction: meta‐analysis of cohort studies
2012
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Mechanical Thrombectomy in Acute Embolic Stroke
2011
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
2012
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Ole Ahlehoff being referenced
Psoriasis and Risk of Heart Failure: A Nationwide Cohort Study
2014
Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use
2010
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention - a retrospective nationwide cohort study
2010
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
2011
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study
2010
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
2011 Standout
Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study
2011
Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study
2012
Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
2011
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study
2011
Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study
2011
Pharmacological Undertreatment of Coronary Risk Factors in Patients with Psoriasis: Observational Study of the Danish Nationwide Registries
2012
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study
2011
Psoriasis and New-Onset Diabetes
2013
[Excess mortality from cardiovascular disease in patients with rheumatoid arthritis].
2011
Psoriasis and Cardiovascular Disease: epidemiological studies.
2011
Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a D anish real‐world cohort study
2012
Nationwide population‐based study of cause‐specific death rates in patients with psoriasis
2014